Teva recalls Clozapine tablets: Potential broken tablets in some bottles
Teva Pharmaceuticals USA recalls 100mg Clozapine tablets (500 count) due to potential broken tablets. Rx only; manufactured in Israel, lot 39C192, expires 06/2019.
Lower-risk recall
Failed Tablet/Capsule Specifications; potential presence of broken tablets.
Contact the company
What happened, in plain English
Teva Pharmaceuticals USA is recalling 100mg Clozapine tablets (500-count bottles) that may contain broken tablets. This could affect patients taking the medication as it might cause issues with proper dosing. Read more at govinfonow.com/recall/41101-teva-recalls-clozapine-tablets-potential-broken-tablets-in-some-bottles.
Source Summary by GovInfoNow · govinfonow.com/recall/41101-teva-recalls-clozapine-tablets-potential-broken-tablets-in-some-bottles · Updated October 7, 2026 · FDA enforcement record: FDA #D-0096-2018
Cite this page
“Teva recalls Clozapine tablets: Potential broken tablets in some bottles.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/41101-teva-recalls-clozapine-tablets-potential-broken-tablets-in-some-bottles. Based on FDA recall #D-0096-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0096-2018%22&limit=1).
Why it’s dangerous
Broken tablets could lead to inconsistent dosing of the medication. Clozapine is a high-risk psychiatric medication that requires precise dosing to avoid serious side effects.
Who’s affected
Patients prescribed Clozapine tablets by a doctor. Those using the medication as directed are most at risk if tablets are broken.
How to tell if you have this one
Check for 100mg Clozapine tablets (500 count) with NDC 00093-7772-05, manufactured in Israel, lot 39C192, expiring 06/2019.
- Brand
Teva- Category
Drug
What to do — step by step
Check Your Medication
Look for 100mg Clozapine tablets (500 count) with NDC 00093-7772-05, manufactured in Israel, lot 39C192, expiring 06/2019.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0096-2018 (November 9, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0096-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.